Heart Failure Oral Therapies at Discharge are Associated with Better Outcome in Acute Heart Failure: A Propensity-Score Matched Study
Étienne Gayat(Inserm), Alexandre Mebazaa(Délégation Paris 5), Katsuya Kajimoto(Seiwa Hospital), Shiro Ishihara(Nippon Steel Yawata Memorial Hospital), Dong‐Ju Choi(Inserm), James L. Januzzi(Massachusetts General Hospital), Jindřich Špinar(Masaryk University), Simona Littnerová(Masaryk University), Khalid F. AlHabib(King Saud University), Mattia Arrigo(University Hospital of Zurich), Johan Lassus(University of Helsinki), Alain Cohen‐Solal(Hôpital Lariboisière), Òscar Miró(Fundació Clínic per a la Recerca Biomèdica), Aldo P. Maggioni(Health Care Foundation), Naoki Sato(British Heart Foundation), Jian Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuhui Zhang(Dalian University), Christian Müller(University Hospital of Basel), Jin Joo Park(Seoul National University Bundang Hospital), Veli‐Pekka Harjola(Polskie Towarzystwo Gastroenterologii), Jiří Pařenica(Masaryk University)
Cited by 130
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k